Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Oncternal Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2024 to 30 Sep 2024.
Oncternal Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2024 was 35%.
Debt-to-equity, Quarterly (%)
Oncternal Therapeutics, Inc. Quarterly Debt-to-equity (%)
Period
Value
YoY Chg
Change %
Date
Q3 2024
35%
30 Sep 2024
Q2 2024
26%
30 Jun 2024
Q1 2024
18%
31 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.